Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4269/ajtmh.20-0302 http://scihub22266oqcxt.onion/10.4269/ajtmh.20-0302 32329432!7253118!32329432     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Trop+Med+Hyg 2020 ; 102 (6): 1189-1190 Nephropedia Template TP {{tp|p=32329432|t=2020. COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions |pdf=|usr=}}{{32329432}} gab.com Text COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions JO: Am J Trop Med Hyg http://www.kidney.de/pget.php?&tw=1&pmid=32329432 #FOAvip Public health measures are needed to resolve the novel coronavirus disease (COVID-19) pandemic, although a looming economic fallout merits close attention. Early safe reintroduction of immune individuals into the workforce may be essential to protecting the economic welfare of communities. Reverse transcriptase-polymerase chain reaction testing, our primary diagnostic tool to date, has sensitivity and timing concerns, owing to sampling/handling errors, as well as a complex virus-host interaction. Reverse transcriptase-polymerase chain reaction assays do not establish immune status once the virus has been cleared. Targeted serosurveillance for the determination of individuals' potential for transmissibility, particularly if paired with direct pathogen testing, may aid in "cleared for business" decision-making. Twit Text FOAVip COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions ????Am J Trop Med Hyg http://www.kidney.de/pget.php?&tw=1&pmid=32329432 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32329432 #FOAvip English Wikipedia <ref>{{Cite pmid|32329432}}</ref> COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions #MMPMID32329432 Krsak M; Johnson SC; Poeschla EM Am J Trop Med Hyg 2020[Jun]; 102 (6): 1189-1190 PMID32329432show ga Public health measures are needed to resolve the novel coronavirus disease (COVID-19) pandemic, although a looming economic fallout merits close attention. Early safe reintroduction of immune individuals into the workforce may be essential to protecting the economic welfare of communities. Reverse transcriptase-polymerase chain reaction testing, our primary diagnostic tool to date, has sensitivity and timing concerns, owing to sampling/handling errors, as well as a complex virus-host interaction. Reverse transcriptase-polymerase chain reaction assays do not establish immune status once the virus has been cleared. Targeted serosurveillance for the determination of individuals' potential for transmissibility, particularly if paired with direct pathogen testing, may aid in "cleared for business" decision-making. |*Pandemics[MESH] |Antibodies, Viral/*blood[MESH] |Betacoronavirus/genetics/immunology/*pathogenicity[MESH] |COVID-19[MESH] |Coronavirus Infections/*diagnosis/*epidemiology/immunology/virology[MESH] |Host-Pathogen Interactions/immunology[MESH] |Humans[MESH] |Immunity, Humoral[MESH] |Immunoassay/standards[MESH] |Immunologic Surveillance[MESH] |Pneumonia, Viral/*diagnosis/*epidemiology/immunology/virology[MESH] |Quarantine/methods[MESH] |RNA, Viral/*genetics[MESH] |Reverse Transcriptase Polymerase Chain Reaction/methods/standards[MESH] |SARS-CoV-2[MESH]COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions (epmc).pdf DeepDyve Pubget Overpricing